Search Results for “treatments” – American ME and CFS Society

SEARCH RESULTS

Or browse all treatments:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Treatment Name	Category	Satisfaction (1-Low 5-High)
Reflexology	COMPLEMENTARY THERAPIES	2 Add rating
Remeron (mirtazapine)	ANTIDEPRESSANTS	Not yet rated. Add rating
Rituxan (rituximab)	IMMUNOMODULATORS	4 Add rating
Royal Jelly	NUTRITIONAL SUPPLEMENTS	Not yet rated. Add rating
Rozerem	HYPNOTICS	Not yet rated. Add rating

AMMES WANTS YOU!
AMMES needs volunteers! AMMES is actively recruiting volunteers to help AMMES grow and prosper. Fundraising coordinator – should have experience …Read More »
WE WANT TO HELP!
Getting help is a priority for people who are ill. This is especially important for ME/CFS patients who have lost their …Read More »
Covid and ME/CFS
Announcement: AMMES has recently added an informational page about COVID-19 and ME/CFS. The page includes physicians’ recommendations regarding the COVID …Read More »
SARS-CoV-2 Mitochondrial Metabolic and Epigenomic Reprogramming in COVID-19
Abstract: To determine the effects of SARS-CoV-2 infection on cellular metabolism, we conducted an exhaustive survey of the cellular metabolic …Read More »
Long COVID-19 and Peripheral Serotonin: A Commentary and Reconsideration
Abstract We believe there are serious problems with a recently published and highly publicized paper entitled “Serotonin reduction in post-acute …Read More »
Recovery of neurophysiological measures in post-COVID fatigue: a 12-month longitudinal follow-up study
Abstract: One of the major consequences of the COVID-19 pandemic has been the significant incidence of persistent fatigue following resolution …Read More »
Exploring the Experience of Healthcare-Related Epistemic Injustice among People with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
Abstract: Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is a chronic, disabling yet clinically “contested” condition, previously theorised through a …Read More »
Fibroblast growth factor receptor inhibitors mitigate the neuropathogenicity of Borrelia burgdorferi or its remnants ex vivo
Abstract: In previous studies, we showed that fibroblast growth factor receptors (FGFRs) contribute to inflammatory mediator output from primary rhesus …Read More »